WhiteHorse Finance (WHF) is rated Hold due to ongoing underfunded dividends and lack of catalysts for a valuation increase. Despite trading at a 40% discount to NAV with a 15% yield, persistent shortfalls in net investment income (NII) and risks of further dividend cuts limit upside potential. Future growth in NII depends on asset sales, Outward Hound’s return to accrual status, and higher loan origination. Shares are expected to remain range-bound until sustainable NII growth is demonstrated to fully fund dividends, despite management optimism.
WhiteHorse Finance's stock and yield context is provided alongside Pluang's snapshot of Financials-sector US stocks as of Oct 08, 2026 08:21 WIB. Among 85 priced Financials stocks, 15 rose and 70 fell. Lufax Holding Ltd traded at USD 0.97 with a 3.86% decline and 99% sell order activity, HSBC Holdings plc was priced at USD 93.82 with a 3.85% drop and 92% buy order activity, while TeraWulf Inc stood at USD 14.43, down 3.61%, with 85% buy orders. Typical hold times ranged from 13 to 36 days across these assets.
Samsung Wallet will launch a new stablecoin feature in late October 2026, available on 82 million U.S. Galaxy devices, allowing users to hold and send stablecoins without separate apps or managing private keys. Bastion, selected as the licensed custo...
The crypto market declined recently due to three main factors: significant outflows from US Bitcoin and Ether spot ETFs, forced liquidation of $651 million in long futures positions, and Federal Reserve minutes indicating a likely further interest ra...
Paxos has integrated XRP into its regulated Crypto Brokerage platform, enabling businesses using its infrastructure to offer XRP for buying, selling, holding, deposits, and withdrawals. This update expands Paxos' asset roster to 29 and supports over ...
Europol's European Cybercrime Centre reports that Bitcoin's blockchain remains secure against quantum computing attacks due to its hash functions. However, about 30% of Bitcoin, roughly 6 to 6.9 million BTC, is held in wallets with exposed public key...
Novo Nordisk is rated as a Buy compared to Eli Lilly because it trades at a significant valuation discount of about 26% to its big pharma peers despite having similar growth rates and a strong dividend yield. The stock is priced at roughly 11.2 times...
